Stock A214150 CLASSYS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings CLASSYS Inc.

Equities

A214150

KR7214150005

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
38,350 KRW +1.99% Intraday chart for CLASSYS Inc. +4.35% +1.59%
2023 Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. CI
2023 Tranche Update on CLASSYS Inc.'s Equity Buyback Plan announced on September 15, 2022. CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Analyst opinion has improved significantly over the past four months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The firm trades with high earnings multiples: 25.11 times its 2024 earnings per share.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLASSYS INC. Stock CLASSYS Inc.
+1.59% 1.79B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.84% 218B
B
DANAHER CORPORATION Stock Danaher Corporation
+7.35% 184B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+13.04% 135B
B-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-1.33% 62.38B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.80% 51.37B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.9B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+0.30% 40.87B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.78% 36.28B -
RESMED, INC. Stock ResMed, Inc.
+26.14% 31.88B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. A214150 Stock
  4. Ratings CLASSYS Inc.